Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Xuqing Zhang, James C Lanter & Zhihua Sui. (2009) Recent advances in the development of selective androgen receptor modulators. Expert Opinion on Therapeutic Patents 19:9, pages 1239-1258.
Read now
Read now
Articles from other publishers (30)
Donald J. AbrahamMichael L. Mohler & James T. Dalton. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
1
103
.
Emiliano Ventura, Anna Gadaj, Gail Monteith, Alexis Ripoche, Jim Healy, Francesco Botrè, Saskia S. Sterk, Tom Buckley & Mark H. Mooney. (2019) Development and validation of a semi-quantitative ultra-high performance liquid chromatography-tandem mass spectrometry method for screening of selective androgen receptor modulators in urine. Journal of Chromatography A 1600, pages 183-196.
Crossref
Crossref
Adam T. Cawley, Corrine Smart, Candace Greer, Marcus Liu Lau & John Keledjian. (2016) Detection of the selective androgen receptor modulator andarine (S-4) in a routine equine blood doping control sample. Drug Testing and Analysis 8:2, pages 257-261.
Crossref
Crossref
Yu Zhou, Jiang Wang, Zhanni Gu, Shuni Wang, Wei Zhu, José Luis Aceña, Vadim A. Soloshonok, Kunisuke Izawa & Hong Liu. (2016) Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas. Chemical Reviews 116:2, pages 422-518.
Crossref
Crossref
Juhyun Kim, Christopher C. Coss & James T. Dalton. (2013) Effect of para halogen modification of S-3-(phenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-trifluoromethyl-phenyl)-propionamides on metabolism and clearance. Archives of Pharmacal Research 37:11, pages 1464-1476.
Crossref
Crossref
Katharina M. Schragl, Guro Forsdahl, Guenter Gmeiner, Valentin S. Enev & Peter Gaertner. (2013) Novel pathway for the synthesis of arylpropionamide-derived selective androgen receptor modulator (SARM) metabolites of andarine and ostarine. Tetrahedron Letters 54:18, pages 2239-2242.
Crossref
Crossref
Thomas P. Burris, Laura A. Solt, Yongjun Wang, Christine Crumbley, Subhashis Banerjee, Kristine Griffett, Thomas Lundasen, Travis Hughes & Douglas J. Kojetin. (2013) Nuclear Receptors and Their Selective Pharmacologic Modulators. Pharmacological Reviews 65:2, pages 710-778.
Crossref
Crossref
Edward J. Kilbourne, Thomas Kenney, Susan Chippari, Christopher McNally, Yihe Wang, Ho-Sun Lam, Karthick Vishwanathan, Sunil Nagpal, Catherine C. Thompson & Eugene L. Piatnitski Chekler. (2013) Probing androgen receptor co-factor selectivity profiles: a chemical tool to determine cross-talk between androgen receptor and β-catenin in vivo. MedChemComm 4:3, pages 582.
Crossref
Crossref
Shayne Cox GadGregory T. Wurz & Michael W. DeGregorio. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.
Mario Thevis, Andreas Thomas, Gregor Fußhöller, Simon Beuck, Hans Geyer & Wilhelm Schänzer. (2010) Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator andarine (S-4) for routine doping control purposes. Rapid Communications in Mass Spectrometry 24:15, pages 2245-2254.
Crossref
Crossref
James T. Dalton & Wenqing Gao. 2010. Nuclear Receptors. Nuclear Receptors
143
182
.
Jeffrey D. Kearbey, Wenqing Gao, Scott J. Fisher, Di Wu, Duane D. Miller & James T. Dalton. (2009) Effects of Selective Androgen Receptor Modulator (SARM) Treatment in Osteopenic Female Rats. Pharmaceutical Research 26:11, pages 2471-2477.
Crossref
Crossref
Mihail F Zilbermint & Adrian S Dobs. (2009)
Nonsteroidal selective androgen receptor modulator Ostarine
™
in cancer cachexia
. Future Oncology 5:8, pages 1211-1220.
Crossref
Crossref
Mario Thevis, Hans Geyer, Matthias Kamber & Wilhelm Schänzer. (2009) Detection of the arylpropionamide‐derived selective androgen receptor modulator (SARM) S‐4 (Andarine) in a black‐market product. Drug Testing and Analysis 1:8, pages 387-392.
Crossref
Crossref
Michael L. Mohler, Casey E. Bohl, Amanda Jones, Christopher C. Coss, Ramesh Narayanan, Yali He, Dong Jin Hwang, James T. Dalton & Duane D. Miller. (2009) Nonsteroidal Selective Androgen Receptor Modulators (SARMs): Dissociating the Anabolic and Androgenic Activities of the Androgen Receptor for Therapeutic Benefit. Journal of Medicinal Chemistry 52:12, pages 3597-3617.
Crossref
Crossref
Eric G. Vajda, Francisco J. López, Peter Rix, Robert Hill, Yanling Chen, Kyoung-Jin Lee, Z. O'Brien, William Y. Chang, Martin D. Meglasson & Yong-Hee Lee. (2009)
Pharmacokinetics and Pharmacodynamics of LGD-3303 [9-Chloro-2-ethyl-1-methyl-3-(2,2,2-trifluoroethyl)-3
H
-pyrrolo-[3,2-
f
]quinolin-7(6
H
)-one], an Orally Available Nonsteroidal-Selective Androgen Receptor Modulator
. Journal of Pharmacology and Experimental Therapeutics 328:2, pages 663-670.
Crossref
Crossref
Michael L. Mohler, Casey E. Bohl, Ramesh Narayanan, Yali He, Dong Jin Hwang, James T. Dalton & Duane D. Miller. 2008. Nuclear Receptors as Drug Targets. Nuclear Receptors as Drug Targets
249
304
.
Tiia Kuuranne, Antti Leinonen, Wilhelm Schänzer, Matthias Kamber, Risto Kostiainen & Mario Thevis. (2008) Aryl-Propionamide-Derived Selective Androgen Receptor Modulators: Liquid Chromatography-Tandem Mass Spectrometry Characterization of the in Vitro Synthesized Metabolites for Doping Control Purposes. Drug Metabolism and Disposition 36:3, pages 571-581.
Crossref
Crossref
Ramesh Narayanan, Michael L. Mohler, Casey E. Bohl, Duane D. Miller & James T. Dalton. (2008) Selective androgen receptor modulators in preclinical and clinical development. Nuclear Receptor Signaling 6:1, pages nrs.06010.
Crossref
Crossref
Jeffrey D. Kearbey, Wenqing Gao, Ramesh Narayanan, Scott J. Fisher, Di Wu, Duane D. Miller & James T. Dalton. (2006) Selective Androgen Receptor Modulator (SARM) Treatment Prevents Bone Loss and Reduces Body Fat in Ovariectomized Rats. Pharmaceutical Research 24:2, pages 328-335.
Crossref
Crossref
A.W. Meikle. 2007. Comprehensive Medicinal Chemistry II. Comprehensive Medicinal Chemistry II
521
540
.
Wenqing Gao, Juhyun Kim & James T. Dalton. (2006) Pharmacokinetics and Pharmacodynamics of Nonsteroidal Androgen Receptor Ligands. Pharmaceutical Research 23:8, pages 1641-1658.
Crossref
Crossref
Jun Yang, Casey E. Bohl, Vipin A. Nair, Suni M. Mustafa, Seoung Soo Hong, Duane D. Miller & James T. Dalton. (2006) Preclinical Pharmacology of a Nonsteroidal Ligand for Androgen Receptor-Mediated Imaging of Prostate Cancer. Journal of Pharmacology and Experimental Therapeutics 317:1, pages 402-408.
Crossref
Crossref
Di Wu, Zengru Wu, Jun Yang, Vipin A. Nair, Duane D. Miller & James T. Dalton. (2006) PHARMACOKINETICS AND METABOLISM OF A SELECTIVE ANDROGEN RECEPTOR MODULATOR IN RATS: IMPLICATION OF MOLECULAR PROPERTIES AND INTENSIVE METABOLIC PROFILE TO INVESTIGATE IDEAL PHARMACOKINETIC CHARACTERISTICS OF A PROPANAMIDE IN PRECLINICAL STUDY. Drug Metabolism and Disposition 34:3, pages 483-494.
Crossref
Crossref
Shalender Bhasin, Olga M Calof, Thomas W Storer, Martin L Lee, Norman A Mazer, Ravi Jasuja, Victor M Montori, Wenqing Gao & James T Dalton. (2006) Drug Insight: testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging. Nature Clinical Practice Endocrinology & Metabolism 2:3, pages 146-159.
Crossref
Crossref
Wenqing Gao, Jeffrey S. Johnston, Duane D. Miller & James T. Dalton. (2006)
INTERSPECIES DIFFERENCES IN PHARMACOKINETICS AND METABOLISM OF
S
-3-(4-ACETYLAMINO-PHENOXY)-2-HYDROXY-2-METHYL-
N
-(4-NITRO-3-TRIFLUOROMETHYLPHENYL)-PROPIONAMIDE: THE ROLE OF
N
-ACETYLTRANSFERASE
. Drug Metabolism and Disposition 34:2, pages 254-260.
Crossref
Crossref
Wenqing Gao, Zengru Wu, Casey E. Bohl, Jun Yang, Duane D. Miller & James T. Dalton. (2006) CHARACTERIZATION OF THE IN VITRO METABOLISM OF SELECTIVE ANDROGEN RECEPTOR MODULATOR USING HUMAN, RAT, AND DOG LIVER ENZYME PREPARATIONS. Drug Metabolism and Disposition 34:2, pages 243-253.
Crossref
Crossref
Juhyun Kim, Di Wu, Dong Jin Hwang, Duane D. Miller & James T. Dalton. (2005)
The
Para
Substituent of
S
-3-(Phenoxy)-2-hydroxy-2-methyl-
N
-(4-nitro-3-trifluoromethyl-phenyl)-propionamides Is a Major Structural Determinant of in Vivo Disposition and Activity of Selective Androgen Receptor Modulators
. Journal of Pharmacology and Experimental Therapeutics 315:1, pages 230-239.
Crossref
Crossref
Wenqing Gao, Casey E. Bohl & James T. Dalton. (2005) Chemistry and Structural Biology of Androgen Receptor. Chemical Reviews 105:9, pages 3352-3370.
Crossref
Crossref
Wenqing Gao, Jeffrey D. Kearbey, Vipin A. Nair, Kiwon Chung, A. F. Parlow, Duane D. Miller & James T. Dalton. (2004) Comparison of the Pharmacological Effects of a Novel Selective Androgen Receptor Modulator, the 5α-Reductase Inhibitor Finasteride, and the Antiandrogen Hydroxyflutamide in Intact Rats: New Approach for Benign Prostate Hyperplasia. Endocrinology 145:12, pages 5420-5428.
Crossref
Crossref